Skip to main content
. Author manuscript; available in PMC: 2018 Nov 2.
Published in final edited form as: Pharmacotherapy. 2017 Nov 2;37(11):1366–1373. doi: 10.1002/phar.2032

Table 3.

Indices of Anticoagulation Attainment and Maintenance by Kidney Transplant status among Warfarin Users with a Therapeutic INR Range of 2–3

Characteristic Patients without Kidney Transplants
(n=1630)
Kidney Transplant Recipients
(n=65)
p Value
Time to first therapeutic INR (days) 19.2 ± 26.2 13.5 ± 20.3 0.033
Follow-up/patient (months) 16.4 ± 10.6 14.0 ± 8.7 0.046
Total no. of visits/patient/month 2.26 ± 1.96 2.74 ± 1.26 < 0.005

Percentage of time below therapeutic range (PTBR) 28.2 ± 26.7 35.4 ± 29.0 0.029
Percentage of time in therapeutic range (PTTR) 48.7 ± 47.4 46.3 ± 41.5 0.34
Percentage of time above therapeutic range (PTAR) 18.0 ± 16.9 18.5 ± 14.8 0.8

Poor anticoagulation control (PTTR < 60) 1023 (62.8) 47 (72.3) 0.11
Good anticoagulation control (PTTR ≥ 60) 607 (37.2) 18 (27.7)

Data are mean ± SD values or no. (%) of patients.

INR = international normalized ratio.